Skip to main content

RA CAPITAL MANAGEMENT, L.P.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1346824 BOSTON, MA

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$46,433,873
-$22,036,414 QoQ
Shares Held
6,053,960
0.0% QoQ
Ownership
9.09%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#2
of 168 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RA CAPITAL MANAGEMENT, L.P. holds $9,134,713,488 across 74 Biotechnology names. FULC ranks #36 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $46,433,873 6,053,960
2025-12-31 $68,470,287 6,053,960
2025-12-08 $78,640,940 6,053,960
2025-09-30 $94,107,710 10,229,099
2025-06-30 $70,376,201 10,229,099
2025-03-31 $29,459,805 10,229,099
2024-12-31 $48,076,765 10,229,099
2024-09-30 $36,517,883 10,229,099
2024-06-30 $71,980,164 11,609,704
2023-12-31 $78,365,502 11,609,704
2023-06-30 $38,312,023 11,609,704
2023-03-31 $33,087,656 11,609,704
2022-12-31 $69,203,134 9,505,925
2022-09-30 $56,630,000 7,000,000